PortfoliosLab logoPortfoliosLab logo
PVLA vs. RAPT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PVLA vs. RAPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Palvella Therapeutics, Inc (PVLA) and RAPT Therapeutics, Inc. (RAPT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


PVLA

1D
10.27%
1M
-9.55%
YTD
10.27%
6M
25.58%
1Y
372.26%
3Y*
5Y*
10Y*

RAPT

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PVLA vs. RAPT - Yearly Performance Comparison


2026 (YTD)20252024
PVLA
Palvella Therapeutics, Inc
10.27%772.25%-6.47%
RAPT
RAPT Therapeutics, Inc.
71.30%167.96%79.28%

Correlation

The correlation between PVLA and RAPT is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2024

0.22

Fundamentals

Market Cap

PVLA:

$1.30B

RAPT:

$1.56B

EPS

PVLA:

-$3.75

RAPT:

-$3.92

PB Ratio

PVLA:

46.41

RAPT:

10.29

Total Revenue (TTM)

PVLA:

$0.00

RAPT:

$0.00

Gross Profit (TTM)

PVLA:

$0.00

RAPT:

-$200.00K

EBITDA (TTM)

PVLA:

-$14.75M

RAPT:

-$108.01M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PVLA vs. RAPT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PVLA
PVLA Risk / Return Rank: 9696
Overall Rank
PVLA Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
PVLA Sortino Ratio Rank: 9595
Sortino Ratio Rank
PVLA Omega Ratio Rank: 9292
Omega Ratio Rank
PVLA Calmar Ratio Rank: 9898
Calmar Ratio Rank
PVLA Martin Ratio Rank: 9797
Martin Ratio Rank

RAPT
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PVLA vs. RAPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Palvella Therapeutics, Inc (PVLA) and RAPT Therapeutics, Inc. (RAPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PVLARAPTDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.49

Calmar ratioReturn relative to maximum drawdown

12.54

Martin ratioReturn relative to average drawdown

28.59

PVLA vs. RAPT - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PVLARAPTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.57

Sharpe Ratio (All Time)

Calculated using the full available price history

4.30

Drawdowns

PVLA vs. RAPT - Drawdown Comparison


Loading charts...

Drawdown Indicators


PVLARAPTDifference

Max Drawdown

Largest peak-to-trough decline

-31.48%

Max Drawdown (1Y)

Largest decline over 1 year

-29.93%

Current Drawdown

Current decline from peak

-22.19%

Average Drawdown

Average peak-to-trough decline

-10.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.10%

Volatility

PVLA vs. RAPT - Volatility Comparison


Loading charts...

Volatility by Period


PVLARAPTDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.98%

Volatility (6M)

Calculated over the trailing 6-month period

62.87%

Volatility (1Y)

Calculated over the trailing 1-year period

82.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

82.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

82.90%

Dividends

PVLA vs. RAPT - Dividend Comparison

Neither PVLA nor RAPT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PVLA vs. RAPT - Financials Comparison

This section allows you to compare key financial metrics between Palvella Therapeutics, Inc and RAPT Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(PVLA) Total Revenue
(RAPT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PVLA and RAPT have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for PVLA and RAPT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer